Fundraising Fox

OpenBench

San Francisco, US · Founded 2019 · Delaware corporation

OpenBench runs AI-enabled structure-based virtual screening to identify small molecule hit series for biotech drug discovery programs, screening large compound libraries and charging only for hits that meet a client-defined profile. It works with clients' own assays and CROs, offering a success-driven model where collaborators purchase resulting IP outright.

Founders & leadership

OpenBench was founded in 2019 by James Thompson and James Yoder.

JT
James ThompsonCo-founder
JYJames Yoder
James YoderCo-founder

Reported raises · per SEC filings

Form D private placements

$2.7M disclosed across 3 rounds · 2020–2021

$2.3MraisedApr 2022 · 16 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • James ThompsonExecutive Officer, Director, Promoter
  • James YoderExecutive Officer, Director, Promoter
Offering amount
$2.5M
Amount sold
$2.3M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$150KraisedApr 2021 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • James ThompsonExecutive Officer, Director, Promoter
  • James YoderExecutive Officer, Director, Promoter
Offering amount
$150K
Amount sold
$150K
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$300KraisedJan 2020 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • James ThompsonExecutive Officer, Director
  • James YoderExecutive Officer, Director
Offering amount
$300K
Amount sold
$300K
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with OpenBench for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does OpenBench do?
OpenBench runs AI-enabled structure-based virtual screening to identify small molecule hit series for biotech drug discovery programs, screening large compound libraries and charging only for hits that meet a client-defined profile. It works with clients' own assays and CROs, offering a success-driven model where collaborators purchase resulting IP outright.
Who founded OpenBench?
OpenBench was founded by James Thompson, James Yoder in 2019.
How much funding has OpenBench raised?
OpenBench has disclosed $2.7M raised across 3 rounds.
Where is OpenBench headquartered?
OpenBench is headquartered in San Francisco, US.